FIRSOCOSTAT |
FIRSOCOSTAT : Inhibitor of ACACA, ACACB
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| ACACA |
|
|
| ACACB |
|
|
Inhibitor
up to 1 μM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
>10 μM
Selectivity Assessment Description:
Ricera DrugMatrix Panel (101 receptors, GFs, transporters, and ion channels).
Data available in SI o ...
Potency Cellular
In Vitro
ACACA
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1073/pnas.1520686113
ACACB
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1073/pnas.1520686113
In Vivo Validations
Rat
Dose: 3 mg/kg
Route of delivery:
Intravenous
Plasma half life:
4.5 h
Systemic clearance:
33 mL/min/kg
Cmax:
6 μM (plasma), 81 μM (liver), 0.6 μM (quadriceps)
Tmax:
0.25 h
Area Under the Curve::
1932 ng.h/mL
Fb :
98.6%
Bioavailability:
37% (oral)
Volume of Distribution at Steady-State:
1.9 L/kg
Organ of interest (O):
Liver, skeletal muscle
DOI Reference: https://doi.org/10.1073/pnas.1520686113
Negative Control Compounds
ND-022
Notes: hACC1 IC50 3.9 μM; hACC2 IC50 6.6 μM (~1000-fold difference)
ChEMBL ID:
CHEMBL4476176
Orthogonal Probes def
MK-4074
Notes: 3 nM potencies for hepatic ACC1/2
ChEMBL ID:
CHEMBL4557289
Chemical Information
| Molecular Formula | C28H31N3O8S |
| SMILEs | COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(=O)O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1 |
| InChI | InChI=1S/C28H31N3O8S/c1-16-21-24(32)31(28(2,3)26(33)34)27(35)30(25(21)40-22(16)23-29-11-14-38-23)15-20(39-17-9-12-37-13-10-17)18-7-5-6-8-19(18)36-4/h5-8,11,14,17,20H,9-10,12-13,15H2,1-4H3,(H,33,34)/t20-/m0/s1 |
| Molecular weight | 569.18 Da |
| AlogP | 3.9533200000000024 |
| HBond acceptors | 11 |
| HBond donors | 1 |
| Atoms | 71 |